Currently Available Treatment Tirzepatide FDA-approved and commercially available as Mounjaro/Zepbound with established dosing protocols and post-market safety data Maximum Weight Loss Potential Retatrutide Phase 3 TRIUMPH-4 data showed 28.7% weight loss at 68 weeks (24.2% at 48 weeks in Phase 2), exceeding tirzepatide's results Non-Alcoholic Fatty Liver Disease Retatrutide Glucagon receptor agonism directly promotes hepatic fat oxidation, showing up to 82% liver fat reduction in trials Type 2 Diabetes Management Tirzepatide Proven HbA1c reduction with FDA approval specifically for glycemic control in type 2 diabetes Continue Your Research Get comparison updates We publish new head-to-head comparisons regularly
Uh, for example, one in about one thousand patients aged sixty six or older with diabetes who use a GLP-1 for at least six months may develop that namd over three years, uh, compared to similar patients not on any of these medications
TB-500 10mg Advanced Tissue Regeneration Research Peptide TB-500 10mg is a research-grade synthetic Thymosin Beta-4 analogue formulated for extended tissue regeneration and advanced recovery research
References 1 BaggioL
The PatchMD Berberine Patch is specifically formulated to complement these medications with targeted nutrients that help support metabolism, glucose regulation, fat-burning pathways, and overall wellness
